Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenase
- 8 February 2023
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 201 (4) , 704-717
Abstract
Amino acids in the bone marrow microenvironment (BMME) are a critical factor for multiple myeloma (MM) progression. Here, we have determined that proline is elevated in BMME of MM patients and links to poor prognosis in MM. Moreover, exogenous proline regulates MM cell proliferation and drug resistance. Elevated proline in BMME is due to bone collagen degradation and abnormal expression of the key enzyme of proline catabolism, proline dehydrogenase (PRODH). PRODH is downregulated in MM patients, mainly as a result of promoter hypermethylation with high expression of DNMT3b. Thus, overexpression of PRODH suppresses cell proliferation and drug resistance of MM and exhibits therapeutic potential for treatment of MM. Altogether, we identify proline as a key metabolic regulator of MM, unveil PRODH governing MM progression and provide a promising therapeutic strategy for MM treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82130006, 81974010, 82270219)
- Hunan Provincial Innovation Foundation for Postgraduate (CX20200261)
This publication has 34 references indexed in Scilit:
- Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cellsNature Communications, 2017
- NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate KinaseJournal of Hematology & Oncology, 2017
- Proline Starvation Induces Unresolved ER Stress and Hinders mTORC1-Dependent TumorigenesisCell Metabolism, 2016
- Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetBlood, 2016
- Extracellular Metabolic Energetics Can Promote Cancer ProgressionCell, 2015
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other CancersCancer Cell, 2013
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Multiple MyelomaNew England Journal of Medicine, 2011
- A Risk PRODH Haplotype Affects Sensorimotor Gating, Memory, Schizotypy, and Anxiety in Healthy Male SubjectsBiological Psychiatry, 2009
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and ProliferationCell Metabolism, 2008